Related Experiment Video
Updated: May 17, 2026
05:21
Establishment of A Mouse Model of Aqueous Deficiency Dry Eye
Published on: November 1, 2024
Thymosin β4: a potential novel dry eye therapy
Gabriel Sosne1, Ping Qiu, George W Ousler
1Department of Ophthalmology, Kresge Eye Institute, Wayne State University School of Medicine, Detroit, Michigan 48201, USA. gsosne@med.wayne.edu
Annals of the New York Academy of Sciences
|October 12, 2012
Summary
Thymosin beta 4 (Tβ4) shows promise as a novel therapy for dry eye syndrome (DES). Animal studies indicate Tβ4 eye drops improve ocular surface healing, supporting clinical investigation for this common inflammatory condition.
Area of Science:
- Ophthalmology
- Immunology
- Pharmacology
Background:
- Dry eye syndrome (DES) is a prevalent ocular surface inflammatory condition affecting millions.
- DES symptoms include burning, irritation, discomfort, and vision impairment.
Purpose of the Study:
- To review the clinical aspects of DES.
- To establish the scientific rationale for using thymosin beta 4 (Tβ4) as a novel DES therapy.
Main Methods:
- Literature review of DES.
- Analysis of existing studies on Tβ4.
- Evaluation of Tβ4's mechanism of action and therapeutic potential.
Main Results:
- Animal studies show Tβ4 eye drops significantly reduce corneal staining in DES models.
- These findings suggest improved wound healing of the ocular surface.
Conclusions:
- Tβ4 demonstrates potential as a safe and effective therapeutic agent for DES.
- Further clinical research is warranted to validate Tβ4's efficacy in human patients.
Related Concept Videos
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:22Microbiome of the Eye
The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...